Our website uses cookies to improve your user experience. If you continue browsing, we assume that you consent to our use of cookies. More information can be found in our Cookies and Privacy Policy. 

X
Skip to content
Employee Benefits
  • News
  • Covid-19
  • Tax & Legal
  • Benefits
  • Events
  • Suppliers
  • Email sign up
Search Login / Register Primary Menu
Close
or Register
news Pay strategy Share schemes Total reward Pay strategy

AstraZeneca boss and staff to receive same pay rises

By Peter Crush 17th February 2021 9:49 am 17th February 2021 9:49 am

Pascal Soirot, CEO of pharmaceutical giant AstraZeneca, will receive the same 3% pay rise as the rest of his staff.

Despite the company’s ongoing success, including seeing its share price jump by 11% after the World Health Organization approved its Covid-19 (Coronavirus) vaccine, the boss’s base salary will increase from £1.29 million to £1.33m – and by the same percentage as the rest of his workforce.

The rise still takes his pay to 197 times the company’s median pay, but Soirot was widely praised for his decision that AstraZeneca should not profit during the pandemic from its vaccine.

While 3% might be considered modest, long-term incentives could see the 61-year-old Frenchman’s total package rise to more than £15m after AstraZeneca proposed increasing the maximum award under his share plan from 550% to 650% of his salary. This could see the maximum possible size of his performance-related awards increase from £7.1m to £8.6m during 2021.

In its annual report, AstraZeneca said the changes being proposed were to “close the gap to market pay levels within the competitive global and European pharmaceutical talent pool.”

It added: “In the last year, it became apparent that the current remuneration policy did not provide the committee with sufficient flexibility to appropriately reward the exceptional performance and growth we expect the executive team to deliver.”

As well as announcing that Soirot’s pay rise would be no larger than anyone else’s, the report also revealed that his pension contributions would be reduced to 11% of base pay – to the same level as the wider workforce. His annual pension contributions will now fall from £258,000 to £146,000 per year.

In 2014 Soirot fought off attempts by US rival Pfizer to buy the company and use it as its headquarters for tax purposes.

Today, the businessis valued at almost £100 billion. AstraZeneca’s shares price has risen by 150% since Soriot took charge in October 2012.

news Employee engagement

Harrods, Jaguar Land Rover and AstraZeneca are named UK’s top employers

15th January 2016 12:05 pm 15th January 2016 12:14 pm
Case studies

AstraZeneca shows off health strategy

24th September 2012 11:52 am 3rd November 2015 5:34 pm
news

AstraZeneca staff set pensions strike dates

25th August 2010 10:25 am 3rd November 2015 6:07 pm
Sign up for the leading independent source of news and expert analysis delivered straight to your inbox. Sign up
Latest ArticlesComments
news Pay strategy

HR pay rises less than the national average

24th February 2021 10:43 am 24th February 2021 10:43 am
news Pay strategy

EHRC confirms extra six months for pay gap reporting

24th February 2021 10:14 am 24th February 2021 10:14 am
news Global reward

HSBC to move to permanent flexible working

24th February 2021 9:21 am 24th February 2021 9:21 am
People Moves Total reward

Edgewell Personal Care promotes Karen Anderson

24th February 2021 9:00 am 23rd February 2021 2:49 pm
  • Cancel reply

    Threaded commenting powered by interconnect/it code.

Explore

  • Email sign up
  • News
  • Benefits
  • Analysis
  • Supplier network
  • Events
  • Jobs
  • Video
  • Buyer’s guide
  • Case studies
  • Opinion
  • Industry sectors
    • Building & Construction
    • Charity / Voluntary
    • Financial Services
    • Healthcare
    • Industry
    • Leisure
    • Logistics
    • Manufacturing
    • Media
    • Pharmaceuticals
    • Professional Services
    • Public Sector
    • Retail
    • Technology / telecommunications
    • Transportation
    • Utilities
  • Digital editions
  • Contact us
  • Twitter
  • LinkedIn
  • Contact us
  • Cookies
  • Privacy
  • Website Terms and Conditions

Copyright @ 2020 DVV Media HR Group Ltd

built by Bournemouth Digital

DVV Media HR Group Limited. Registered in England and Wales no. 6776955.

Registered office 1st Floor Chancery House, St Nicholas Way, Sutton, Surrey SM1 1JB